Frameshift deletion mechanisms in Egyptian Duchenne and becker muscular dystrophy families

Molecules and Cells

Volumn 18, Issue 2, 2004, Pages 141-149

  Elhawary Nasser, A ^b   Shawky, Rabah Mohamad ^a   Hashem, Nemat ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Dystrophin gene; Egyptian population; Frameshift deletions; Multiplex PCR

Indexed keywords

DYSTROPHIN; GENOMIC DNA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CONTROLLED STUDY; DELETION MUTANT; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; EGYPT; FAMILY STUDY; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE DELETION; GENE DISRUPTION; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC DIFFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; TRANSLATION INITIATION;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DYSTROPHIN; EGYPT; EPIDEMIOLOGY, MOLECULAR; EXONS; FAMILY HEALTH; FRAMESHIFT MUTATION; HUMANS; INFANT; MALE; MUSCULAR DYSTROPHY, DUCHENNE; OPEN READING FRAMES; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 11444264901     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Abdel-fattah, M. M., Fahmy, A. F., Aid, S. Z., Hashem, N., and Elhawary, N. A. (2003) Molecular diagnosis of deletional mutation in Duchenne and Becker muscular dystrophies using multiplex PCR in Egyptian population. Egypt. J. Med. Hum. Genet. 4, 12-24.
2. Bartlett, R. J., Stockinger, S., Denis, M. M., Bartlett, W. T., Inverardi, L., Le T. T., thi Man, N., Morris, G. E., Bogan, D. J., Metcalf-Bogan, J., and Kornegay, J. N. (2000) In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat. Biotechnol. 18, 615-622.
3. Barton-Davis, E. R., Cordier, L., Shoturma, D. I., Leland, S. E., and Sweeney, H. L. (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J. Clin. Invest. 104, 375-381.
4. Baumbach, L. L., Chamberlain, J. S., Ward, P. S., Farwell, N. J., and Caskey, C. T. (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39, 465-474.
5. Beggs, A. H., Koenig, M., Boyce, F. M., and Kunkel, L. M. (1990) PCR primers for the dystrophin gene that complement existing ones to detect over 98% of DMD/BMD deletions. Hum. Genet. 86, 46-48.
6. Beggs, A. H., Hoffman, E. P., Snyder, J. R., Arahata, K., Specht, L., Shapiro, F., Angelini, C., Sugita, H., and Kunkel, L. M. (1991) Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am. J. Hum. Genet. 49, 54-67.
7. Behrman, R. E., Kligman, R. M., and Jenson, H. B. (2000) Duchenne and Becker muscular dystrophy, Nelson Textbook, Vol. 4, pp. 1874-1877, 16th ed.
8. Cagliani, R., Sironi, M., Ciafaloni, E., Bardoni, A., Fortunato, F., Prelle, A., Serafini, M., Bresolin, N., and Comi, G. P. (2004) An intragenic deletion/inversion event in the DMD gene determines a novel exon creation and results in a BMD phenotype. Hum. Genet. 115, 13-18.
9. Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N., and Caskey, C. T. (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16, 11141-11156.
10. Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N., and Caskey, C. T. (1990) Multiplex PCR for diagnosis of Duchenne muscular dystrophy; in PCR Protocols: A Guide to Methods and Applications, Innis, M. A., Gelfand, D. H., Sninsky, J. J., and White, T. J. (eds.), pp. 272-281, Academic Press, New York.
11. Chamberlain, J. S., Chamberlain, J. R., Fenwick, R. G., Ward, P. A., Dimnik, L. S., Bech-Hansen, N. T., Tantranvahi, U., et al. (1992) Diagnostic of Duchenne and Becker muscular dystrophies by polymerase chain reaction: a multicenter study. J. Am. Med. Assoc. 267, 2609-2615.
12. Dincer, P., Topaloglu, H., Ayter, S., Ozguc, M., Tasdemir, H. A., and Renda, Y. (1996) Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients. Brain Dev. 18, 91-94.
13. Dubowitz, V. (1990) The Duchenne dystrophy story: from phenotype to gene and potential treatment. J. Child. Neurol. 4 240-250.
14. Effat, L. K., El-Harouni, A. A., Amr, K. S., El-Minisi, T. I., Abdel-Meguid, N., and El-Awady, M. (2000) Screening of dystrophin gene deletions in Egyptian patients with DMD/BMD muscular dystrophies. Dis. Markers 16, 125-129.
15. Elsayed, N. S. (1998) The phenotypic expression of myopathy genes prevalent among Egyptians. M.S. Dissertation, Faculty of Medicine, AinShams University, Cairo.
16. Ervasti, J. M. and Campbell, K. P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131.
17. Gillard, E. F., Chamberlain, J. S., Murphy, E. G., Duff, C. L., Smith, B., Burghes, A. H. M., Thompson, M. W., et al. (1989) Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am. J. Hum. Genet. 45, 507-520.
18. Ginjaar, I. B., Kneppers, A. L., v d Meulen, J. D., Anderson, L. V., Bremmer-Bout, M., van Deutekom, J. C., Weegnaar, J., den Dunnen J. T., and Bakker, E. (2000) Dystrophin nonsense mutations induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family. Eur. J. Hum. Genet. 8, 793-796.
19. Hart, K. A., Hodgson, S., Walker, A., Cole, C. G., Johnson, L., Dubowitz, V., and Bobrow, M. (1987) DNA deletions in mild and severe Becker dystrophy. Hum. Genet. 75, 281-285.
20. Hashem, N. (1982) Preventable aspects of genetic morbility Vol. II, Medical Genetics Center, pp. 320-324, Al-Ahram Press, Cairo, Egypt.
21. Hoffman, E. P., Brown, R. H., and Kunkel, L. M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
22. Hoffman, E. P., Fischbeck, K. H., Brown, R. H., Johnson, M., Medori, R., Loike, J. D., Harris, J. B., et al. (1988) Characterization of dystrophin In muscle biopsy specimens from patients with Duchenne or Becker muscular dystrophy. N. Engl. J. Med. 318 1363-1368.
23. Hoop, R. C., Russo, L. S., Riconda, L. S., Schwartz, L. S., and Hoffman, E. P. (1994) Restoration of half the normal dystrophin sequence in a double-deletion Duchenne muscular dystrophy family. Am. J. Med. Genet. 49, 323-327.
24. Hu, X., Ray, P. N., Murphy, E. G., Thompson, M. W., and Worton, R. G. (1990) Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotype/genotype correlation. Am. J. Hum. Genet. 46, 682-695.
25. Kim, U. K., Chae, J. J., Lee, S. H., Lee, C. C., and Namkoong, Y. (2002) Molecular diagnosis of Duchenne muscular dystrophy by polymerase chain reaction and microsatellite analysis. Mol. Cells 13, 385-388.
26. Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., et al. (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45, 498-506.
27. Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., and Kunkel, L. M. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517.
28. Koenig, M., Monaco, A. P., and Kunkel, L. M. (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219-226.
29. Malhotra, S. B., Hart, K. A., Klamut, H. J., Thomas, N. S. T., Bodrug, S. E., Burghes, A. H. M., Bobrow, M., et al. (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242, 755-759.
30. Matsuo, M., Masumura, T., Nishio, H., Nakajima, T., Kitoh, Y., Takumi, T., Koga, J., and Nakamura, H. (1991) Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J. Clin. Invest. 87, 2127-2131.
31. McCabe, E., Huang, S. Z., Seltzer, W. K., and Law, M. L. (1987) DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum. Genet. 75, 213-216.
32. Mendell, J. R., Buzin, C. H., Feng, J., Yan, J., Serrano, C., Sangani, D. S., Wall, C., Prior, T. W., and Sommer, S. S. (2001) Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology 57, 645-650.
33. Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H., and Kunkel, K. L. (1988) An explanation for the phenotypic differences between patients bearing partial deletions of DMD locus. Genomics 2, 90-95.
34. Narita, N., Nishio, H., Kitoh, Y., Ishikawa, Y., Minami, R., Nakamura, H., and Matsuo, M. (1993) Insertion of a 5′ truncated L1 element into the 3′ end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J. Clin. Invest. 91, 1862-1867.
35. Odinokova, O. N., Puzyrev, V. P., Radzhabaliev, Sh. F., and Rakhmonov, R. A. (1996) Deletion analysis of the dystrophin gene in patients with Duchenne's muscular dystrophy in Tajikistan. Genetika 32, 1392-1395.
36. Patino, A., Narbona, J., and Garcia-Delgado, M. (1995) Molecular analysis of the Duchenne muscular dystrophy gene in Spanish individuals: deletion detection and familial diagnosis. Am. J. Med. Genet. 59, 182-187.
37. Rando, T. A., Disatnik, M. H., and Zhou, L. Z. (2000) Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc. Natl. Acad. Sci. USA 97, 5363-5368.
38. Richards, B., Skoletsky, J., Shuber, A. P., Balfour, R. C., Stern, H. L., Dorkin, R. B., Parad, R. B., et al. (1993) Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swaps. Hum. Mol. Genet. 2, 159-163.
39. Roberts, R. G. (1995) Dystrophin, its gene, and the dystrinopathies. Adv. Genet. 33, 177-231.
40. Shomrat, R., Gluck, E., Legum, C., and Shiloh, Y. (1994) Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients. Am. J. Med. Genet. 49, 369-373.
41. Thanh, L. T., Nguyen, M. T., Helliwell, T. R., and Morris, G. E. (1995) Characterization of revertant muscle fibers in Duchenne muscular dystrophy using exon-specific monoclonal antibodies against dystrophin. Am. J. Hum. Genet. 56, 725-731.
42. van Deutekom, J. C. T., Bremmer-Bout, M., Janson, A. A. M., Ginjaar, I. B., Baas, F., den Dunnen, J. T., and van Ommen, G. J. B. (2001) Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet. 10, 1547-1554.
43. Wagner, K. R., Hamed, S., and Hadley, D. W. (2001) Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann. Neurol. 49, 706-711.
44. Wheway, J. M., Yau, S. C., Nihalani, V., Ellis, D., Irving, M., Splitt, M., and Roberts, R. G (2003) A complex deletion-inversion-deletion event results in a chimeric IL 1RAPL1-dystrophin transcript and a contiguous gene deletion syndrome. J. Med. Genet. 40, 127-131.
45. Winnard, A. V., Mendel, J. R., Prior, T. W., Florence, J., and Burghes, A. H. M. (1995) Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am. J. Hum. Genet. 56, 158-166.
46. Yoshida, M. and Ozawa, E. (1990) Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. 108, 748-752.